Multicenter Exploratory Trial of the Safety and Efficacy of Adjuvant Docetaxel and Carboplatin in Patients With Resected Non-Small Cell Lung Cancer
Phase of Trial: Phase IV
Latest Information Update: 17 Dec 2013
At a glance
- Drugs Carboplatin (Primary) ; Docetaxel (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 01 Dec 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 Aug 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 02 Mar 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.